Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age. The Kaiser-UCLA Vaccine Study Group (Q41119154)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 1996
edit
Language Label Description Also known as
English
Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age. The Kaiser-UCLA Vaccine Study Group
scientific article published on June 1996

    Statements

    Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age. The Kaiser-UCLA Vaccine Study Group (English)
    Greenberg DP
    Vadheim CM
    Marcy SM
    Partridge S
    Jing J
    Chiu CY
    Greene T
    Margolis HS
    Ward JI
    1 June 1996
    811-816

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit